Patricia M. Danzon : Citation Profile


Are you Patricia M. Danzon?

University of Pennsylvania

16

H index

23

i10 index

956

Citations

RESEARCH PRODUCTION:

42

Articles

14

Papers

3

Books

5

Chapters

EDITOR:

1

Books edited

RESEARCH ACTIVITY:

   36 years (1982 - 2018). See details.
   Cites by year: 26
   Journals where Patricia M. Danzon has often published
   Relations with other researchers
   Recent citing documents: 64.    Total self citations: 20 (2.05 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pda291
   Updated: 2021-11-20    RAS profile: 2020-03-06    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon.

Is cited by:

Brekke, Kurt (18)

Pammolli, Fabio (18)

Jelovac, Izabela (15)

Jimenez-Martin, Sergi (13)

Magazzini, Laura (13)

Straume, Odd Rune (13)

Kyle, Margaret (11)

Cabrales, Antonio (11)

Riccaboni, Massimo (11)

Pertile, Paolo (10)

Costa-Font, Joan (10)

Cites to:

DiMasi, Joseph (7)

Szymanski, Stefan (7)

Cockburn, Iain (7)

Valletti, Tommaso (7)

Dranove, David (6)

Newhouse, Joseph (4)

Salkever, David (4)

Kyle, Margaret (4)

Henderson, Rebecca (4)

Acemoglu, Daron (3)

Hudson, John (3)

Main data


Where Patricia M. Danzon has published?


Journals with more than one article published# docs
Health Economics5
Journal of Health Economics5
Journal of Law and Economics5
Journal of Policy Analysis and Management4
International Journal of the Economics of Business3
American Economic Review2
The Journal of Legal Studies2
The Journal of Business2
Managerial and Decision Economics2

Recent works citing Patricia M. Danzon (2021 and 2020)


YearTitle of citing document
2020The impact of competition on vertical integration: The role of technological niche width. (2020). Park, Wooyong ; Khurshid, Faisal. In: Business Strategy and the Environment. RePEc:bla:bstrat:v:29:y:2020:i:3:p:789-800.

Full description at Econpapers || Download paper

2020Spillover effects of increased health insurance enrollment on workers’ compensation insurance. (2020). Cole, Cassandra R ; Baggett, Courtney B ; Sirmans, Tice E ; Crowley, George . In: Risk Management and Insurance Review. RePEc:bla:rmgtin:v:23:y:2020:i:1:p:53-74.

Full description at Econpapers || Download paper

2020Dynamic Mergers Effects on R&D Investments and Drug Development across Research Phases in the Pharmaceutical Industry. (2020). Tian, Zhili ; Siebert, Ralph. In: CESifo Working Paper Series. RePEc:ces:ceswps:_8303.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl ; Benito, Raquel Fonseca. In: CIRANO Working Papers. RePEc:cir:cirwor:2020s-16.

Full description at Econpapers || Download paper

2020A comparative analysis of medicine prices in Latin America. (2020). Gonzalez, Aldo ; Alvarez, Roberto. In: Revista CEPAL. RePEc:ecr:col070:45974.

Full description at Econpapers || Download paper

2021Let us work together: The impact of customer strategic alliances on IPO underpricing and post-IPO performance. (2021). Wang, Xiongyuan ; Chan, Kam C ; Jia, Yibo ; Peng, Xuan. In: Journal of Corporate Finance. RePEc:eee:corfin:v:67:y:2021:i:c:s0929119921000201.

Full description at Econpapers || Download paper

2021Group firms’ access to internal capital markets: The contingent roles of group resources and affiliates’ financial weakness. (2021). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: Economic Modelling. RePEc:eee:ecmode:v:96:y:2021:i:c:p:135-156.

Full description at Econpapers || Download paper

2021Pooled procurement of drugs in low and middle income countries. (2021). Straub, Stephane ; Lefouili, Yassine ; Dubois, Pierre. In: European Economic Review. RePEc:eee:eecrev:v:132:y:2021:i:c:s0014292121000088.

Full description at Econpapers || Download paper

2021Overcoming inefficiencies in the development of personalized medicine. (2021). Wuttke, David A ; Heese, Sebastian H ; Lutkemeyer, Daniel. In: European Journal of Operational Research. RePEc:eee:ejores:v:290:y:2021:i:1:p:278-296.

Full description at Econpapers || Download paper

2020How to address medicines shortages: Findings from a cross-sectional study of 24 countries. (2020). Fischer, Stefan ; Vogler, Sabine. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:12:p:1287-1296.

Full description at Econpapers || Download paper

2021Welfare effects of public procurement of medicines: Evidence from Ecuador. (2021). Mohapatra, Debi Prasad ; Callejas, Jeronimo. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:75:y:2021:i:c:s016771872030120x.

Full description at Econpapers || Download paper

2021Mergers and innovation: Evidence from the hard disk drive market. (2021). Ormosi, Peter ; Mariuzzo, Franco ; Davies, Stephen ; Bennato, Anna Rita. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:77:y:2021:i:c:s0167718721000485.

Full description at Econpapers || Download paper

2021Capital, aggregate risk, insurance prices and regulation. (2021). Wang, Jinjing ; Subramanian, Ajay. In: Insurance: Mathematics and Economics. RePEc:eee:insuma:v:100:y:2021:i:c:p:156-192.

Full description at Econpapers || Download paper

2021Economic capital and RAROC in a dynamic model. (2021). Zanjani, George ; Bauer, Daniel. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:125:y:2021:i:c:s0378426621000297.

Full description at Econpapers || Download paper

2020The effect of inertia on brand-name versus generic drug choices. (2020). Kobayashi, Yasuki ; Hara, Konan ; Ito, Yuki. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:172:y:2020:i:c:p:364-379.

Full description at Econpapers || Download paper

2020Risk transfer and moral hazard: An examination on the market for insurance-linked securities. (2020). Gurtler, Marc ; Gotze, Tobias. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:180:y:2020:i:c:p:758-777.

Full description at Econpapers || Download paper

2020The effect of malpractice law on physician supply: Evidence from negligence-standard reforms. (2020). Frank, Matthew B ; Frakes, Michael D ; Seabury, Seth A. In: Journal of Health Economics. RePEc:eee:jhecon:v:70:y:2020:i:c:s0167629618302042.

Full description at Econpapers || Download paper

2020Optimal price regulations in international pharmaceutical markets with generic competition. (2020). Saggi, Kamal ; Geng, Difei. In: Journal of Health Economics. RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303844.

Full description at Econpapers || Download paper

2021Cross-border mergers and acquisitions for innovation. (2021). HSU, Po-Hsuan ; Humphery-Jenner, Mark ; Huang, Peng ; Powell, Ronan. In: Journal of International Money and Finance. RePEc:eee:jimfin:v:112:y:2021:i:c:s026156062030276x.

Full description at Econpapers || Download paper

2020Network failure: Biotechnology firms, clusters and collaborations far from the world superclusters. (2020). Lusher, Dean ; Bunton, Vikki ; Brennecke, Julia ; Gilding, Michael ; Codoreanu, Alex ; Molloy, Peter L. In: Research Policy. RePEc:eee:respol:v:49:y:2020:i:2:s0048733319302203.

Full description at Econpapers || Download paper

2021Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling. (2021). Chatterjee, Chirantan ; Yan, Xin ; Higgins, Matthew J. In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:1:s0048733320302018.

Full description at Econpapers || Download paper

2021Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials. (2021). Häussler, Carolin ; Assmus, Anne ; Haeussler, Carolin . In: Research Policy. RePEc:eee:respol:v:50:y:2021:i:2:s0048733320302298.

Full description at Econpapers || Download paper

2021Legal Fees, Cost-Shifting Rules and Litigation: Experimental Evidence. (2021). Tisserand, Jean-Christian ; Peterle, Emmanuel ; Gabuthy, Yannick. In: Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics). RePEc:eee:soceco:v:93:y:2021:i:c:s2214804321000458.

Full description at Econpapers || Download paper

2020Association between provincial income levels and drug prices in China over the period 2010–2017. (2020). Yang, Xiuyun ; Mossialos, Elias ; Liu, Gordon ; Wouters, Olivier J ; Shi, Wunan. In: Social Science & Medicine. RePEc:eee:socmed:v:263:y:2020:i:c:s0277953620304664.

Full description at Econpapers || Download paper

2020Data portability effects on data-driven innovation of online platforms: Analyzing Spotify. (2020). Blind, Knut ; Ramos, Esmeralda Florez. In: Telecommunications Policy. RePEc:eee:telpol:v:44:y:2020:i:9:s030859612030118x.

Full description at Econpapers || Download paper

2020Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market. (2020). Yan, Weijie. In: Papers. RePEc:esr:wpaper:wp678.

Full description at Econpapers || Download paper

2021Effects of R&D Investments and Market Signals on International Acquisitions: Evidence from IPO Firms. (2021). Wu, Cheng-Wei ; Reuer, Jeffrey J. In: Journal of Risk and Financial Management. RePEc:gam:jjrfmx:v:14:y:2021:i:5:p:191-:d:541083.

Full description at Econpapers || Download paper

2020Moderating Effect of the Continental Factor on the Business Strategy and M&A Performance in the Pharmaceutical Industry for Sustainable International Business. (2020). Lee, Kun Chang ; Kim, Cheong ; Kwon, Jinhee. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:12:p:4985-:d:373245.

Full description at Econpapers || Download paper

2021The Impact of Mergers and Acquisitions and Sustainability on Company Performance in the Pharmaceutical Sector. (2021). Opreana, Alin ; Erban, Radu-Alexandru ; Mihaiu, Diana Marieta ; BARBU, Liliana ; Brtian, Vasile ; Ichindelean, Mihai. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:12:p:6525-:d:570910.

Full description at Econpapers || Download paper

2021Drug Discovery Firms and Business Alliances for Sustainable Innovation. (2021). Sengoku, Shintaro ; Kodama, Kota ; Wang, Huayi ; Harada, Yoshimi. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:7:p:3599-:d:523033.

Full description at Econpapers || Download paper

2020The influence of local institutional and historical frameworks on a globalized industry: The case of the pharmaceutical industry in France and Quebec. (2020). Geymond, Mae. In: Post-Print. RePEc:hal:journl:halshs-02900915.

Full description at Econpapers || Download paper

2021Rushed Innovation: Evidence from Drug Licensing. (2021). Hermosilla, Manuel. In: Management Science. RePEc:inm:ormnsc:v:67:y:2021:i:1:p:257-278.

Full description at Econpapers || Download paper

2020How Does Court Stability Affect Legal Stability?. (2020). Bustos, Alvaro. In: Documentos de Trabajo. RePEc:ioe:doctra:535.

Full description at Econpapers || Download paper

2020Two-way selection between flat-fee attorneys and litigants: theoretical and empirical analyses. (2020). Tu, Su-Hao ; Chang, Yun-Chien. In: European Journal of Law and Economics. RePEc:kap:ejlwec:v:49:y:2020:i:1:d:10.1007_s10657-017-9566-3.

Full description at Econpapers || Download paper

2020The impact of regulation on private security industry dynamics. (2020). Reniers, Genserik ; Cools, Marc ; Buts, Caroline ; Scheerlinck, Glenn. In: European Journal of Law and Economics. RePEc:kap:ejlwec:v:50:y:2020:i:2:d:10.1007_s10657-020-09663-5.

Full description at Econpapers || Download paper

2021Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy. (2021). Naegelen, Florence ; Marechal, Franois ; Alcenat, Stephane. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:21:y:2021:i:1:d:10.1007_s10754-020-09290-2.

Full description at Econpapers || Download paper

2020A scientometric analysis of knowledge spillover research. (2020). Ferreira, Joao ; Fernandes, Cristina ; Cerver-Romero, Elvira. In: The Journal of Technology Transfer. RePEc:kap:jtecht:v:45:y:2020:i:3:d:10.1007_s10961-018-9698-9.

Full description at Econpapers || Download paper

2020The Welfare Effects of Spotify’s Cross-Country Price Discrimination. (2020). Waldfogel, Joel. In: Review of Industrial Organization. RePEc:kap:revind:v:56:y:2020:i:4:d:10.1007_s11151-020-09748-0.

Full description at Econpapers || Download paper

2020The value of innovation and the spillover effect on alliance partners. (2020). Zheng, Qiancheng ; Sutton, Ninon K ; Qi, Jianping. In: Review of Quantitative Finance and Accounting. RePEc:kap:rqfnac:v:55:y:2020:i:4:d:10.1007_s11156-020-00879-9.

Full description at Econpapers || Download paper

2021Earnings management surrounding forced CEO turnover: evidence from the U.S. property-casualty insurance industry. (2021). Lin, Tzuting ; Cummins, David J ; Cheng, Jiang. In: Review of Quantitative Finance and Accounting. RePEc:kap:rqfnac:v:56:y:2021:i:3:d:10.1007_s11156-020-00910-z.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Michaud, Pierre-Carl ; Langot, Francois ; Fonseca, Raquel. In: NBER Working Papers. RePEc:nbr:nberwo:26876.

Full description at Econpapers || Download paper

2020Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination. (2020). Wasserman, Melissa F ; Frakes, Michael D. In: NBER Working Papers. RePEc:nbr:nberwo:27579.

Full description at Econpapers || Download paper

2021Under pressure: investment behaviour of insurers under different financial and regulatory conditions. (2021). Reddic, Willie Dion. In: The Geneva Papers on Risk and Insurance - Issues and Practice. RePEc:pal:gpprii:v:46:y:2021:i:1:d:10.1057_s41288-020-00174-7.

Full description at Econpapers || Download paper

2020Regionalization of R&D activities: (Dis)economies of interdependence and inventive performance. (2020). Roy, Raja ; Lampert, Curba Morris ; Kim, Minyoung. In: Journal of International Business Studies. RePEc:pal:jintbs:v:51:y:2020:i:7:d:10.1057_s41267-020-00314-0.

Full description at Econpapers || Download paper

2020Ill health and distraction at work: Costs and drivers for productivity loss. (2020). Bialowolski, Piotr ; Weziak-Bialowolska, Dorota ; Vanderweele, Tyler J ; McNeely, Eileen. In: PLOS ONE. RePEc:plo:pone00:0230562.

Full description at Econpapers || Download paper

2020Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study. (2020). Mohammed, Fuad Adem ; Woldekidan, Nigist Alemayehu. In: PLOS ONE. RePEc:plo:pone00:0235205.

Full description at Econpapers || Download paper

2020Efficient Liability in Expert Markets. (2020). Zhang, Jin ; Li, Jianpei ; Chen, Yongmin. In: MPRA Paper. RePEc:pra:mprapa:104090.

Full description at Econpapers || Download paper

2020Efficient Liability in Expert Markets. (2020). Chen, Yongmin ; Zhang, Jin ; Li, Jianpei. In: MPRA Paper. RePEc:pra:mprapa:104326.

Full description at Econpapers || Download paper

2021Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?. (2021). Versaevel, Bruno ; Scannell, Jack ; de Villemeur, Etienne Billette. In: MPRA Paper. RePEc:pra:mprapa:108233.

Full description at Econpapers || Download paper

2021The Long Shadow of an Infection: COVID-19 and Performance at Work. (2021). Schmal, Wolfgang ; Reade, J ; Fischer, Kai. In: Economics Discussion Papers. RePEc:rdg:emxxdp:em-dp2021-17.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl. In: Cahiers de recherche / Working Papers. RePEc:rsi:creeic:2004.

Full description at Econpapers || Download paper

2021Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment. (2021). Kourouklis, Dimitrios ; Giudice, Pietro ; Shaikh, Mujaheed. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00601-9.

Full description at Econpapers || Download paper

2020Does external reference pricing deliver what it promises? Evidence on its impact at national level. (2020). Efthymiadou, Olina ; Gill, Jennifer ; Fontrier, Anna-Maria ; Kanavos, Panos. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:1:d:10.1007_s10198-019-01116-4.

Full description at Econpapers || Download paper

2021Does NICE influence the adoption and uptake of generics in the UK?. (2021). ONeill, Phill ; Mestre-Ferrandiz, Jorge ; Bianchi, Simona ; Serra-Sastre, Victoria. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:2:d:10.1007_s10198-020-01245-1.

Full description at Econpapers || Download paper

2021Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study. (2021). Nerg, Iiro ; Ala-Mursula, Leena ; Rissanen, Ina ; Korhonen, Marko. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:4:d:10.1007_s10198-021-01271-7.

Full description at Econpapers || Download paper

2020Innovation for and from emerging countries: a closer look at the antecedents of trickle-down and reverse innovation. (2020). Giannetti, Verdiana ; Rubera, Gaia. In: Journal of the Academy of Marketing Science. RePEc:spr:joamsc:v:48:y:2020:i:5:d:10.1007_s11747-019-00669-3.

Full description at Econpapers || Download paper

2020How Does Partner Selection Affect IPO Performance?. (2020). Chung, Pi-Hui. In: Advances in Management and Applied Economics. RePEc:spt:admaec:v:10:y:2020:i:4:f:10_4_5.

Full description at Econpapers || Download paper

2021Knowledge dynamics in employee entrepreneurship : Implications for parents and offspring. (2021). Chila, Vilma. In: Other publications TiSEM. RePEc:tiu:tiutis:a1f5d18c-783b-4af6-8414-61a224f6a525.

Full description at Econpapers || Download paper

2021Price cap regulation in the Colombian pharmaceutical market: An impact evaluation. (2021). Bardey, David ; Zuluaga, Daniela ; Harker, Arturo. In: TSE Working Papers. RePEc:tse:wpaper:125385.

Full description at Econpapers || Download paper

2020On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector. (2019). Sæthre, Morten ; Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:32393.

Full description at Econpapers || Download paper

2020On the Effect of Parallel Trade on Manufacturers and Retailers Profits in the Pharmaceutical Sector. (2020). Sæthre, Morten ; Dubois, Pierre ; Sathre, Morten. In: Econometrica. RePEc:wly:emetrp:v:88:y:2020:i:6:p:2503-2545.

Full description at Econpapers || Download paper

2021A reply to “Who would benefit from average value?based pricing?”. (2021). Pertile, Paolo ; Levaggi, Rosella. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:9:p:2284-2286.

Full description at Econpapers || Download paper

2021INNOVATION AND DIFFUSION OF MEDICAL TREATMENT. (2021). Papageorge, Nicholas ; Hamilton, Barton H ; Miller, Robert A ; Hincapie, Andres. In: International Economic Review. RePEc:wly:iecrev:v:62:y:2021:i:3:p:953-1009.

Full description at Econpapers || Download paper

2021The long shadow of an infection: COVID-19 and performance at work. (2021). Schmal, Wolfgang ; Reade, J ; Fischer, Kai. In: DICE Discussion Papers. RePEc:zbw:dicedp:368.

Full description at Econpapers || Download paper

Patricia M. Danzon has edited the books:


YearTitleTypeCited

Works by Patricia M. Danzon:


YearTitleTypeCited
1988The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review.
[Full Text][Citation analysis]
article2
1990The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review.
[Full Text][Citation analysis]
article7
1990THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME..(1990) In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
This paper has another version. Agregated cites: 7
paper
1991Liability for Medical Malpractice In: Journal of Economic Perspectives.
[Full Text][Citation analysis]
article46
2000Liability for medical malpractice.(2000) In: Handbook of Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 46
chapter
1994Health Care Reform In: Australian Economic Review.
[Full Text][Citation analysis]
article4
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]
article35
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 35
chapter
2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 35
paper
1994The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics.
[Full Text][Citation analysis]
article3
2008Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance.
[Full Text][Citation analysis]
article7
1997Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation.
[Full Text][Citation analysis]
article85
2000Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics.
[Full Text][Citation analysis]
article80
1982Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics.
[Full Text][Citation analysis]
article16
2002Welfare effects of supplementary insurance: a comment In: Journal of Health Economics.
[Full Text][Citation analysis]
article8
2005Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics.
[Full Text][Citation analysis]
article62
2003Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 62
paper
1985Liability and liability insurance for medical malpractice In: Journal of Health Economics.
[Full Text][Citation analysis]
article15
1984Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics.
[Full Text][Citation analysis]
article3
2012Regulation of the Biopharmaceutical Industry In: Chapters.
[Full Text][Citation analysis]
chapter0
1990Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]
paper2
2002Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs.
[Full Text][Citation analysis]
paper0
2014Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters.
[Full Text][Citation analysis]
chapter2
1999The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters.
[Full Text][Citation analysis]
chapter2
2004Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers.
[Full Text][Citation analysis]
paper55
2007Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 55
article
2008Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper18
2011Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers.
[Full Text][Citation analysis]
paper11
2015Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 11
article
2011Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers.
[Full Text][Citation analysis]
paper3
2011Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 3
article
2011Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers.
[Full Text][Citation analysis]
paper10
2012Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers.
[Full Text][Citation analysis]
paper15
2015Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15
article
2002Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers.
[Full Text][Citation analysis]
paper56
2003The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers.
[Full Text][Citation analysis]
paper71
2005The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s.(2005) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 71
article
1997Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monographs.
[Full Text][Citation analysis]
book5
2000Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monographs.
[Full Text][Citation analysis]
book2
2002The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monographs.
[Full Text][Citation analysis]
book5
2011Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Papers.
[Full Text][Citation analysis]
paper2
1994Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy.
[Citation analysis]
article1
1990Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article3
1983Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics.
[Full Text][Citation analysis]
article43
2018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics.
[Full Text][Citation analysis]
article6
2015Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article0
1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
article30
1993The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics.
[Full Text][Citation analysis]
article13
2002Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics.
[Full Text][Citation analysis]
article16
1984The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article31
1993Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article0
2000Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics.
[Full Text][Citation analysis]
article88
2001Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics.
[Full Text][Citation analysis]
article10
1997Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article6
2001Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies.
[Full Text][Citation analysis]
article0
1994Price Cutting in Liability Insurance Markets. In: The Journal of Business.
[Full Text][Citation analysis]
article24
2000Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business.
[Full Text][Citation analysis]
article6
2002A general model of the impact of absenteeism on employers and employees In: Health Economics.
[Full Text][Citation analysis]
article31
1999Medical negligence and the NHS: an economic analysis In: Health Economics.
[Full Text][Citation analysis]
article6
1995A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1982Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article0
1983Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]
article1
2007Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics.
[Full Text][Citation analysis]
article4

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2021. Contact: CitEc Team